Cargando…
HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort
The aim of this study was to evaluate whether the presence of anti-hepatitis B (HBV) c antibodies (HBcAb positivity) could influence the control of Human Immunodeficiency Virus (HIV) viremia in patients living with HIV (PLWH) who switch a to two-drug antiretroviral therapy (2DR) containing lamivudin...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919011/ https://www.ncbi.nlm.nih.gov/pubmed/33671934 http://dx.doi.org/10.3390/microorganisms9020396 |
_version_ | 1783658052523655168 |
---|---|
author | Malagnino, Vincenzo Teti, Elisabetta Compagno, Mirko Coppola, Luigi Salpini, Romina Svicher, Valentina Basso, Monica Battagin, Giuliana Panese, Sandro Rossi, Maria Cristina Scaggiante, Renzo Zago, Daniela Iannetta, Marco Parisi, Saverio Giuseppe Andreoni, Massimo Sarmati, Loredana |
author_facet | Malagnino, Vincenzo Teti, Elisabetta Compagno, Mirko Coppola, Luigi Salpini, Romina Svicher, Valentina Basso, Monica Battagin, Giuliana Panese, Sandro Rossi, Maria Cristina Scaggiante, Renzo Zago, Daniela Iannetta, Marco Parisi, Saverio Giuseppe Andreoni, Massimo Sarmati, Loredana |
author_sort | Malagnino, Vincenzo |
collection | PubMed |
description | The aim of this study was to evaluate whether the presence of anti-hepatitis B (HBV) c antibodies (HBcAb positivity) could influence the control of Human Immunodeficiency Virus (HIV) viremia in patients living with HIV (PLWH) who switch a to two-drug antiretroviral therapy (2DR) containing lamivudine (3TC) (2DR-3TC). A retrospective observational multicenter study was conducted on 166 PLWH switching to the 2DR-3TC-based regimen: 58 HBcAb-positive and 108 HBcAb-negative patients. The HBcAb-positive PLWH group demonstrated a significantly higher percentage of subjects with very low-level viremia at all time points after switching (6th month: <31% vs. 17.6%, p = 0.047; 12th month 34% vs. 27.5%, p = 0.001; 24th month 37% vs. 34.2, p = 0.003 of the HBcAb-positive and HBcAb-negative groups, respectively) and a higher percentage of subjects with detectable HIV RNA greater than 20 copies/mL 12 and 24 months after switching (12 months 32% vs. 11%, p = 0.001; 24 months 37% vs. 13.9%, p = 0.003 of the HBcAb-positive and HBcAb-negative groups, respectively). Logistic regression analysis showed that an increase in age of ten years (OR 2.48 (95% CI 1.58–3.89), p < 0.0001) and the presence of HBcAb positivity (OR 2.7 (5% CI 1.05–6.9), p = 0.038) increased the risk of detectability of HIV RNA by nearly three-fold after switching to 2DR-3TC. |
format | Online Article Text |
id | pubmed-7919011 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79190112021-03-02 HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort Malagnino, Vincenzo Teti, Elisabetta Compagno, Mirko Coppola, Luigi Salpini, Romina Svicher, Valentina Basso, Monica Battagin, Giuliana Panese, Sandro Rossi, Maria Cristina Scaggiante, Renzo Zago, Daniela Iannetta, Marco Parisi, Saverio Giuseppe Andreoni, Massimo Sarmati, Loredana Microorganisms Article The aim of this study was to evaluate whether the presence of anti-hepatitis B (HBV) c antibodies (HBcAb positivity) could influence the control of Human Immunodeficiency Virus (HIV) viremia in patients living with HIV (PLWH) who switch a to two-drug antiretroviral therapy (2DR) containing lamivudine (3TC) (2DR-3TC). A retrospective observational multicenter study was conducted on 166 PLWH switching to the 2DR-3TC-based regimen: 58 HBcAb-positive and 108 HBcAb-negative patients. The HBcAb-positive PLWH group demonstrated a significantly higher percentage of subjects with very low-level viremia at all time points after switching (6th month: <31% vs. 17.6%, p = 0.047; 12th month 34% vs. 27.5%, p = 0.001; 24th month 37% vs. 34.2, p = 0.003 of the HBcAb-positive and HBcAb-negative groups, respectively) and a higher percentage of subjects with detectable HIV RNA greater than 20 copies/mL 12 and 24 months after switching (12 months 32% vs. 11%, p = 0.001; 24 months 37% vs. 13.9%, p = 0.003 of the HBcAb-positive and HBcAb-negative groups, respectively). Logistic regression analysis showed that an increase in age of ten years (OR 2.48 (95% CI 1.58–3.89), p < 0.0001) and the presence of HBcAb positivity (OR 2.7 (5% CI 1.05–6.9), p = 0.038) increased the risk of detectability of HIV RNA by nearly three-fold after switching to 2DR-3TC. MDPI 2021-02-15 /pmc/articles/PMC7919011/ /pubmed/33671934 http://dx.doi.org/10.3390/microorganisms9020396 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Malagnino, Vincenzo Teti, Elisabetta Compagno, Mirko Coppola, Luigi Salpini, Romina Svicher, Valentina Basso, Monica Battagin, Giuliana Panese, Sandro Rossi, Maria Cristina Scaggiante, Renzo Zago, Daniela Iannetta, Marco Parisi, Saverio Giuseppe Andreoni, Massimo Sarmati, Loredana HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort |
title | HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort |
title_full | HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort |
title_fullStr | HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort |
title_full_unstemmed | HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort |
title_short | HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort |
title_sort | hbcab positivity is a risk factor for an increased detectability of hiv rna after switching to a two-drug regimen lamivudine-based (2dr-3tc-based) treatment: analysis of a multicenter italian cohort |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919011/ https://www.ncbi.nlm.nih.gov/pubmed/33671934 http://dx.doi.org/10.3390/microorganisms9020396 |
work_keys_str_mv | AT malagninovincenzo hbcabpositivityisariskfactorforanincreaseddetectabilityofhivrnaafterswitchingtoatwodrugregimenlamivudinebased2dr3tcbasedtreatmentanalysisofamulticenteritaliancohort AT tetielisabetta hbcabpositivityisariskfactorforanincreaseddetectabilityofhivrnaafterswitchingtoatwodrugregimenlamivudinebased2dr3tcbasedtreatmentanalysisofamulticenteritaliancohort AT compagnomirko hbcabpositivityisariskfactorforanincreaseddetectabilityofhivrnaafterswitchingtoatwodrugregimenlamivudinebased2dr3tcbasedtreatmentanalysisofamulticenteritaliancohort AT coppolaluigi hbcabpositivityisariskfactorforanincreaseddetectabilityofhivrnaafterswitchingtoatwodrugregimenlamivudinebased2dr3tcbasedtreatmentanalysisofamulticenteritaliancohort AT salpiniromina hbcabpositivityisariskfactorforanincreaseddetectabilityofhivrnaafterswitchingtoatwodrugregimenlamivudinebased2dr3tcbasedtreatmentanalysisofamulticenteritaliancohort AT svichervalentina hbcabpositivityisariskfactorforanincreaseddetectabilityofhivrnaafterswitchingtoatwodrugregimenlamivudinebased2dr3tcbasedtreatmentanalysisofamulticenteritaliancohort AT bassomonica hbcabpositivityisariskfactorforanincreaseddetectabilityofhivrnaafterswitchingtoatwodrugregimenlamivudinebased2dr3tcbasedtreatmentanalysisofamulticenteritaliancohort AT battagingiuliana hbcabpositivityisariskfactorforanincreaseddetectabilityofhivrnaafterswitchingtoatwodrugregimenlamivudinebased2dr3tcbasedtreatmentanalysisofamulticenteritaliancohort AT panesesandro hbcabpositivityisariskfactorforanincreaseddetectabilityofhivrnaafterswitchingtoatwodrugregimenlamivudinebased2dr3tcbasedtreatmentanalysisofamulticenteritaliancohort AT rossimariacristina hbcabpositivityisariskfactorforanincreaseddetectabilityofhivrnaafterswitchingtoatwodrugregimenlamivudinebased2dr3tcbasedtreatmentanalysisofamulticenteritaliancohort AT scaggianterenzo hbcabpositivityisariskfactorforanincreaseddetectabilityofhivrnaafterswitchingtoatwodrugregimenlamivudinebased2dr3tcbasedtreatmentanalysisofamulticenteritaliancohort AT zagodaniela hbcabpositivityisariskfactorforanincreaseddetectabilityofhivrnaafterswitchingtoatwodrugregimenlamivudinebased2dr3tcbasedtreatmentanalysisofamulticenteritaliancohort AT iannettamarco hbcabpositivityisariskfactorforanincreaseddetectabilityofhivrnaafterswitchingtoatwodrugregimenlamivudinebased2dr3tcbasedtreatmentanalysisofamulticenteritaliancohort AT parisisaveriogiuseppe hbcabpositivityisariskfactorforanincreaseddetectabilityofhivrnaafterswitchingtoatwodrugregimenlamivudinebased2dr3tcbasedtreatmentanalysisofamulticenteritaliancohort AT andreonimassimo hbcabpositivityisariskfactorforanincreaseddetectabilityofhivrnaafterswitchingtoatwodrugregimenlamivudinebased2dr3tcbasedtreatmentanalysisofamulticenteritaliancohort AT sarmatiloredana hbcabpositivityisariskfactorforanincreaseddetectabilityofhivrnaafterswitchingtoatwodrugregimenlamivudinebased2dr3tcbasedtreatmentanalysisofamulticenteritaliancohort |